Skip to content
Search

Latest Stories

Submit Guest Post

UK watchdog bans adverts claiming to cure ADHD and autism in children

Advertising Standards Authority cracks down on 'unacceptable' supplement promotions targeting vulnerable families

ADHD autism ad ban UK

Approved treatments exist to help manage ADHD symptoms through the NHS

Representative image - iStock

Highlights

  • ASA bans misleading adverts promising to cure autism and ADHD in children through food supplements.
  • EllaOla Facebook promotion claimed supplements lead to "fewer meltdowns" and children "trying NEW foods".
  • Over 500,000 people waiting for ADHD assessment in England, driving demand for unproven treatments.

Adverts for food supplements falsely claiming to cure autism and ADHD in children have been banned by Britain's advertising watchdog.

The Advertising Standards Authority (ASA) criticised the "unacceptable" online promotions as part of a sweeping crackdown on supplements claiming to treat neurodivergent conditions.


One Facebook promotion by EllaOla promised parents of autistic children that supplements could lead to "fewer meltdowns", "more energy & alertness" and even "trying NEW foods".

Israeli-based nutrition clinic Customized Autism Treatment claimed, "Autism Recovery Supplement" pills would treat ADHD symptoms, while UK brand Get Dopa said the phrase "the perfect gift for anyone with ADHD" came from an external customer review and the advert using the review was withdrawn after concerns were raised.

Get Dopa said its advert did not claim that its product improves clarity, focus, or energy for ADHD was not directed towards children. The ASA ruling on Get Dopa involved an implied medical claim created by a customer testimonial referencing ADHD, which appeared alongside general, authorised nutrition claims

The ASA said such adverts risked "misleading vulnerable people or steering those who need it away from appropriate medical advice".

Expert warnings escalate

Henry Shelford, co-founder of ADHD UK, said the charity was "constantly having to stop whatever is today's 'magical' supplement being promoted as an ADHD cure", as people wait for NHS appointments.

Jolanta Lasota, chief executive of Ambitious about Autism, warned parents of autistic children faced "online scammers offering fake cures that could in fact be incredibly harmful".

"There is no cure for autism, but we've seen dangerous social media adverts targeting online autism communities with bogus treatments, including edible psychedelics and bleach," she told The Telegraph.

Neither autism nor ADHD can be cured, though approved treatments exist to help manage ADHD symptoms through the NHS.
Long NHS waiting lists are driving demand for alternative treatments.

October figures showed over 500,000 people waiting for ADHD assessment in England. At current rates, ADHD UK claimed clearing the backlog would take 2,000 years.

Autism and ADHD are both forms of neurodivergence with overlapping traits and can often occur together. Get Dopa responded it intended to promote products as food supplements, not medical treatments, believing its claims were "general health claims".

Customized Autism Treatment said its advert was not intentionally created and may have appeared through automated online programmes, pledging preventive action.

EllaOla confirmed it had removed the advertisement and would not use it again.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

Menopause in South Asian Women

Researchers say menopause timing could offer important clues about a woman's future heart health

iStock

South Asian women more likely than Europeans to face early menopause and heart disease risk

  • South Asian women were found to have a 34 per cent higher risk of premature menopause than European women.
  • Women in low and middle-income countries were 53 per cent more likely to experience premature menopause.
  • Early and premature menopause were linked to a higher risk of heart attacks, strokes and other major cardiovascular events.

An international study has found that South Asian women are more likely to experience premature menopause than women from many other ethnic groups, raising concerns about a lesser-known risk factor for heart disease and stroke.

The research, published in The Lancet Obstetrics, Gynaecology & Women's Health, analysed data from more than 111,000 women across 26 countries and found that both premature menopause and early menopause were significantly more common in low and middle-income countries. Researchers say the findings could have important implications for women's cardiovascular health, particularly in regions where heart disease is already a growing concern.

Keep ReadingShow less